scholarly journals The Outer Vestibule of the Na+ Channel–Toxin Receptor and Modulator of Permeation as Well as Gating

Marine Drugs ◽  
2010 ◽  
Vol 8 (4) ◽  
pp. 1373-1393 ◽  
Author(s):  
René Cervenka ◽  
Touran Zarrabi ◽  
Peter Lukacs ◽  
Hannes Todt
1981 ◽  
Vol 78 (2) ◽  
pp. 1245-1249 ◽  
Author(s):  
Y. Berwald-Netter ◽  
N. Martin-Moutot ◽  
A. Koulakoff ◽  
F. Couraud

1995 ◽  
Vol 69 (5) ◽  
pp. 1657-1665 ◽  
Author(s):  
S.C. Dudley ◽  
H. Todt ◽  
G. Lipkind ◽  
H.A. Fozzard

2001 ◽  
Vol 80 (2) ◽  
pp. 698-706 ◽  
Author(s):  
Jennifer L. Penzotti ◽  
Gregory Lipkind ◽  
Harry A. Fozzard ◽  
Samuel C. Dudley
Keyword(s):  

2012 ◽  
Vol 140 (4) ◽  
pp. 435-454 ◽  
Author(s):  
Chien-Jung Huang ◽  
Laurent Schild ◽  
Edward G. Moczydlowski

Voltage-gated Na+ channels (NaV channels) are specifically blocked by guanidinium toxins such as tetrodotoxin (TTX) and saxitoxin (STX) with nanomolar to micromolar affinity depending on key amino acid substitutions in the outer vestibule of the channel that vary with NaV gene isoforms. All NaV channels that have been studied exhibit a use-dependent enhancement of TTX/STX affinity when the channel is stimulated with brief repetitive voltage depolarizations from a hyperpolarized starting voltage. Two models have been proposed to explain the mechanism of TTX/STX use dependence: a conformational mechanism and a trapped ion mechanism. In this study, we used selectivity filter mutations (K1237R, K1237A, and K1237H) of the rat muscle NaV1.4 channel that are known to alter ionic selectivity and Ca2+ permeability to test the trapped ion mechanism, which attributes use-dependent enhancement of toxin affinity to electrostatic repulsion between the bound toxin and Ca2+ or Na+ ions trapped inside the channel vestibule in the closed state. Our results indicate that TTX/STX use dependence is not relieved by mutations that enhance Ca2+ permeability, suggesting that ion–toxin repulsion is not the primary factor that determines use dependence. Evidence now favors the idea that TTX/STX use dependence arises from conformational coupling of the voltage sensor domain or domains with residues in the toxin-binding site that are also involved in slow inactivation.


1998 ◽  
Vol 75 (6) ◽  
pp. 2647-2657 ◽  
Author(s):  
Jennifer L. Penzotti ◽  
Harry A. Fozzard ◽  
Gregory M. Lipkind ◽  
Samuel C. Dudley
Keyword(s):  

2000 ◽  
Vol 116 (6) ◽  
pp. 781-790 ◽  
Author(s):  
Peter M. Snyder ◽  
Daniel B. Bucher ◽  
Diane R. Olson

The epithelial Na+ channel (ENaC) is comprised of three homologous subunits (α, β, and γ). The channel forms the pathway for Na+ absorption in the kidney, and mutations cause disorders of Na+ homeostasis. However, little is known about the mechanisms that control the gating of ENaC. We investigated the gating mechanism by introducing bulky side chains at a position adjacent to the extracellular end of the second membrane spanning segment (549, 520, and 529 in α, β, and γENaC, respectively). Equivalent “DEG” mutations in related DEG/ENaC channels in Caenorhabditis elegans cause swelling neurodegeneration, presumably by increasing channel activity. We found that the Na+ current was increased by mutagenesis or chemical modification of this residue and adjacent residues in α, β, and γENaC. This resulted from a change in the gating of ENaC; modification of a cysteine at position 520 in βENaC increased the open state probability from 0.12 to 0.96. Accessibility to this side chain from the extracellular side was state-dependent; modification occurred only when the channel was in the open conformation. Single-channel conductance decreased when the side chain contained a positive, but not a negative charge. However, alterations in the side chain did not alter the selectivity of ENaC. This is consistent with a location for the DEG residue in the outer vestibule. The results suggest that channel gating involves a conformational change in the outer vestibule of ENaC. Disruption of this mechanism could be important clinically since one of the mutations that increased Na+ current (γN530K) was identified in a patient with renal disease.


2016 ◽  
Vol 113 (21) ◽  
pp. 5856-5861 ◽  
Author(s):  
Rhiannon Thomas-Tran ◽  
J. Du Bois

Improper function of voltage-gated sodium channels (NaVs), obligatory membrane proteins for bioelectrical signaling, has been linked to a number of human pathologies. Small-molecule agents that target NaVs hold considerable promise for treatment of chronic disease. Absent a comprehensive understanding of channel structure, the challenge of designing selective agents to modulate the activity of NaV subtypes is formidable. We have endeavored to gain insight into the 3D architecture of the outer vestibule of NaV through a systematic structure–activity relationship (SAR) study involving the bis-guanidinium toxin saxitoxin (STX), modified saxitoxins, and protein mutagenesis. Mutant cycle analysis has led to the identification of an acetylated variant of STX with unprecedented, low-nanomolar affinity for human NaV1.7 (hNaV1.7), a channel subtype that has been implicated in pain perception. A revised toxin-receptor binding model is presented, which is consistent with the large body of SAR data that we have obtained. This new model is expected to facilitate subsequent efforts to design isoform-selective NaV inhibitors.


Sign in / Sign up

Export Citation Format

Share Document